Program

Conference Program
Domestic Registration
Int’l Registration

2021 Co-Chairs

Tamar Raz, PhD, CEO, Hadassit – Technology Transfer Company of Hadassah Medical Organization

Tamar Raz, PhD – CEO

Prior to joining Hadasit, Tamar served as VP Marketing and Strategy at Ramot, the Technology Transfer Company of Tel Aviv University, and was responsible for the company strategic alliances, marketing activities and commercialization. Tamar managed the establishment and served as CEO of Allergene, an Israeli start-up company that was founded as an incubator project.

Tamar’s PhD and MSc were earned in Cell Biology from Tel Aviv University School of Medicine. Expertise include; commercialization of medical technologies from the academic/ laboratory bench to the industry in order to  turn ideas into viable products and services;  establishment and management of  corporate and academic relationships, pre-clinical development operations;  raising funds including investment of venture capital, corporate collaborations, contractual research relationships and government grants.

Keren Primo Cohen, CEO, RAMOT at Tel Aviv University Ltd. 

Keren Primor Cohen – CEO

Keren Primor Cohen is the CEO of Ramot, the Technology Transfer Company of Tel-Aviv University.
Keren is responsible for the management and commercial development of all technologies and intellectual property arising from TAU research and innovation initiatives.
This includes industry liaison, IP management, business development, technology commercialization, and the formation of startups around TAU technologies.
Keren is also the Managing Partner of Momentum Fund, a $24M fund that invests in early stage promising innovative technologies from TAU, and serves as a Board Member at various TAU start-ups.
Keren also serves as a board member at TAU Ventures, a subsidiary of Ramot, and an accelerator that invests in early, highly innovative startups that have been founded by undergraduates and graduates of TAU.
Keren is also a member of the National Committee for Research and Development for Academic and Industry Relations.
Keren holds a B.A. in Economics and LL.B. and LL.M., all from Tel Aviv University, and has been a member of the Israeli Bar Association since 2000.

Guest Speaker:

Dr. Simon S. Litvin, CEO/President, GEN TRIZ, USA, PhD, TRIZ Master 

Dr. Simon Litvin is one of the world’s foremost experts on innovation methodology, including TRIZ, Value Engineering, Six Sigma, etc. He has more than 40 years of experience developing, teaching, and implementing innovative methods. Dr. Litvin is one of the architects of advanced TRIZ methodology – GEN TRIZ. Dr. Litvin is one of the authors of modern Function Analysis, Trimming and Feature Transfer techniques, Cause-Effect Chain Analysis, Function-Oriented Search, and Main Parameters of Value Discovery.

Dr. Litvin is the founder and CEO/President of GEN TRIZ, LLC the biggest TRIZ-based company in the world. Dr. Litvin led numerous international consulting projects for Fortune 500 companies such as Alcoa, British American Tobacco, Clorox, Colgate-Palmolive, General Electric, Intel, Kimberly-Clark, Mars, Novartis, GSK, Pepsi, Owens-Illinois, P&G, Siemens, Tyco, and Unilever.

Dr. Litvin has over 110 publications to his credit, including 7 books and more than 30 patents. Dr. Litvin is a Vice President R&D of International TRIZ Association (MATRIZ) and Chairman of TRIZ Master Certification Board. He is also a member of Altshuller Institute for TRIZ Studies and European TRIZ Association (ETRIA).

Event Structure

Conference Program

In Collaboration With:

Platinum Sponsors:

Gold Sponsors:

Silver Sponsors:

Venue & Opening Hours

David Intercontinental Hotel, Tel-Aviv.

Monday, March 15, 2021,  08:00 – 16:30

Contact Us